carnitine has been researched along with Pervasive Child Development Disorders in 5 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Disorders of carnitine biosynthesis have recently been associated with neurodevelopmental syndromes such as autism spectrum disorder (ASD)." | 7.81 | Improvement of regressive autism symptoms in a child with TMLHE deficiency following carnitine supplementation. ( Beaudet, AL; Comeaux, MS; Elsea, SH; Scaglia, F; Schaaf, CP; Sun, Q; Yang, Y; Ziats, MN, 2015) |
| "Disorders of carnitine biosynthesis have recently been associated with neurodevelopmental syndromes such as autism spectrum disorder (ASD)." | 3.81 | Improvement of regressive autism symptoms in a child with TMLHE deficiency following carnitine supplementation. ( Beaudet, AL; Comeaux, MS; Elsea, SH; Scaglia, F; Schaaf, CP; Sun, Q; Yang, Y; Ziats, MN, 2015) |
| "L-carnitine was proposed as a potential treatment for patients diagnosed with an autism spectrum disorder to improve mitochondrial dysfunction, but no prior randomized controlled trials have been conducted." | 2.76 | A prospective double-blind, randomized clinical trial of levocarnitine to treat autism spectrum disorders. ( Adams, JB; Davis, G; Geier, DA; Geier, MR; Kern, JK; King, PG; Young, JL, 2011) |
| "Autism spectrum disorder (ASD) with intellectual disability (ID) is a life-long debilitating condition, which is characterized by cognitive function impairment and other neurological signs." | 1.42 | Autism and intellectual disability associated with mitochondrial disease and hyperlactacidemia. ( Cauli, O; González-Guevara, L; Guevara-Campos, J, 2015) |
| "Acyl-carnitine panels were determined to be abnormal if three or more individual acyl-carnitine species were abnormal in the panel and these abnormalities were verified by repeated testing." | 1.39 | Unique acyl-carnitine profiles are potential biomarkers for acquired mitochondrial disease in autism spectrum disorder. ( Frye, RE; Macfabe, DF; Melnyk, S, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Guevara-Campos, J | 1 |
| González-Guevara, L | 1 |
| Cauli, O | 1 |
| Ziats, MN | 1 |
| Comeaux, MS | 1 |
| Yang, Y | 1 |
| Scaglia, F | 1 |
| Elsea, SH | 1 |
| Sun, Q | 1 |
| Beaudet, AL | 1 |
| Schaaf, CP | 1 |
| Thomas, RH | 1 |
| Foley, KA | 1 |
| Mepham, JR | 1 |
| Tichenoff, LJ | 1 |
| Possmayer, F | 1 |
| MacFabe, DF | 2 |
| Geier, DA | 1 |
| Kern, JK | 1 |
| Davis, G | 1 |
| King, PG | 1 |
| Adams, JB | 1 |
| Young, JL | 1 |
| Geier, MR | 1 |
| Frye, RE | 1 |
| Melnyk, S | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Chart Review to Evaluate the Safety and Efficacy of Magnetic EEG/ECG-Guided Resonance Therapy (MeRT) on Subjects With Autism Spectrum Disorder (ASD)[NCT02758496] | 141 participants (Actual) | Observational | 2016-04-30 | Completed | |||
| A Longitudinal Study on the Safety and Efficacy for Subjects With Autism Spectrum Disorder (ASD) Who Received Magnetic EEG/ECG-Guided Resonance Therapy (MeRT)[NCT02746445] | 11 participants (Actual) | Observational | 2016-04-30 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for carnitine and Pervasive Child Development Disorders
| Article | Year |
|---|---|
A prospective double-blind, randomized clinical trial of levocarnitine to treat autism spectrum disorders.
Topics: Carnitine; Child; Child Development Disorders, Pervasive; Child, Preschool; Cognition; Cohort Studie | 2011 |
4 other studies available for carnitine and Pervasive Child Development Disorders
| Article | Year |
|---|---|
Autism and intellectual disability associated with mitochondrial disease and hyperlactacidemia.
Topics: Carnitine; Child Development Disorders, Pervasive; Child, Preschool; Female; Folic Acid; Humans; Hyp | 2015 |
Improvement of regressive autism symptoms in a child with TMLHE deficiency following carnitine supplementation.
Topics: Autism Spectrum Disorder; Autistic Disorder; Cardiomyopathies; Carnitine; Child Development Disorder | 2015 |
Altered brain phospholipid and acylcarnitine profiles in propionic acid infused rodents: further development of a potential model of autism spectrum disorders.
Topics: Animals; Behavior, Animal; Brain; Carnitine; Child; Child Development Disorders, Pervasive; Chromato | 2010 |
Unique acyl-carnitine profiles are potential biomarkers for acquired mitochondrial disease in autism spectrum disorder.
Topics: Biomarkers; Carnitine; Child; Child Development Disorders, Pervasive; Cohort Studies; DNA, Mitochond | 2013 |
Unique acyl-carnitine profiles are potential biomarkers for acquired mitochondrial disease in autism spectrum disorder.
Topics: Biomarkers; Carnitine; Child; Child Development Disorders, Pervasive; Cohort Studies; DNA, Mitochond | 2013 |
Unique acyl-carnitine profiles are potential biomarkers for acquired mitochondrial disease in autism spectrum disorder.
Topics: Biomarkers; Carnitine; Child; Child Development Disorders, Pervasive; Cohort Studies; DNA, Mitochond | 2013 |
Unique acyl-carnitine profiles are potential biomarkers for acquired mitochondrial disease in autism spectrum disorder.
Topics: Biomarkers; Carnitine; Child; Child Development Disorders, Pervasive; Cohort Studies; DNA, Mitochond | 2013 |